BioDelivery Sciences International leverages its novel and proprietary patented drug delivery technologies to develop and commercialize new applications of proven therapeutics with a focus on pain management and oncology supportive care.  In addition to other candidates in development, BioDelivery’s pain franchise currently consists of two products utilizing the patented BEMA technology: ONSOLIS, for the management of breakthrough pain in opioid tolerant, adult patients with cancer; and BEMA Buprenorphine, in development for the treatment of moderate to severe chronic pain. For more information, visit the company’s Web site at www.bdsi.com

ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year’s annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 11-14. Bringing together executives from more than 400 growth companies, the 24th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com

Let us hear your thoughts below: